Status:
COMPLETED
Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Care
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
Asklepios Kliniken Hamburg GmbH
Conditions:
Unipolar Depression
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Aim of the current study is to investigate the acceptance and efficacy of Metacognitive Training for Depression (D-MCT) compared to cognitive remediation in outpatients with major depressive disorders...
Detailed Description
Evidence-based treatments for depression include pharmacological and psychological interventions. Within psychological interventions, cognitive behavioral therapy (CBT) is one of the most extensively ...
Eligibility Criteria
Inclusion
- informed consent
- age between 18 and 70 years
- diagnosis of a single Episode or recurrent Major depressive disorder (MDD) or dysthymia (verified by the MINI)
Exclusion
- lifetime psychotic symptoms (i.e., hallucinations, delusions, or mania), suicidality (Suicidal Behaviors Questionnaire-Revised ≥ 7), intellectual disability (estimated IQ \< 70) or dementia.
Key Trial Info
Start Date :
October 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2019
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03268434
Start Date
October 10 2017
End Date
September 24 2019
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asklepios Klinik Nord-Ochsenzoll
Hamburg, Germany, 22419